Does Dr. ARTHUR LEE have financial conflicts of interest?

Dr. ARTHUR LEE (MD) has received a total of $1,201,181 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $1,189,636 in personal promotional payouts (consulting, meals, travel) and $11,545 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ARTHUR LEE?

According to CMS Open Payments data, Dr. ARTHUR LEE received funding from JANSSEN PHARMACEUTICALS ($371,848), AMGEN ($268,785), and BOEHRINGER INGELHEIM PHARMACEUTICALS ($146,726).

Does Dr. ARTHUR LEE receive research grants or speaking fees?

Dr. ARTHUR LEE has received $1,189,636 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $11,545 in clinical research grants.

DR. ARTHUR LEE

MDReal-Time Hydrated

Specialty: Internal Medicine, Interventional Cardiology

Practice Location: GAINESVILLE, FL 32605

NPI Number: 1063447977

LIFETIME INDUSTRY VALUE

$1,201,181

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. LEE is a verified Internal Medicine, Interventional Cardiology practitioner based in GAINESVILLE, FL.

Between 2021 and 2024, Dr. LEE had an overall industry promotional and research financial footprint of $1,201,181 as recorded in the federal CMS Open Payments database.

$1,189,636 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$11,545 was allocated to sponsored clinical trials and medical research activities.

Dr. LEE's primary funding source is JANSSEN PHARMACEUTICALS, which accounts for $371,848 (representing 31% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

JANSSEN PHARMACEUTICALS

Rank 1

$371,848

31%

AMGEN

Rank 2

$268,785

22.4%

BOEHRINGER INGELHEIM PHARMACEUTICALS

Rank 3

$146,726

12.2%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.